We conducted a cluster analysis of patients with inflammatory bowel disease receiving anti-TNF treatment from GSE16879 dataset based on four AIM2 inflammasome-related genes, and the optimal clusters were produced when K = 2 (Fig. 6A,B). This evidence concerns the gene AIM2 and inflammatory bowel disease.